40
Participants
Start Date
March 15, 2024
Primary Completion Date
March 14, 2025
Study Completion Date
March 14, 2025
Carotenoid Group
Treatment will contain 20mg free lutein (10mg/softgel), 4 mg free zeaxanthin (2mg/softgel), 40mg maqui berry extract (20mg/softgel), 6 mg astaxanthin (3 mg/softgel), 80mg bilberry extract (40mg/softgel), flaxseed oil (150mg/softgel), and vitamin E (5IU/softgel)
Control (placebo) group
Flaxseed Oil (330mg)
University of illinois, Urbana
Daiken Biomedical Co., Ltd.
UNKNOWN
University of Illinois at Urbana-Champaign
OTHER